Bridger Management, LLC / VRTX
Bridger Management, LLC’s Vertex Pharmaceuticals Inc Position
Does Bridger Management, LLC own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 18.8K shares worth $7M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$7M
Q3 2025
Shares
18.8K
% of Portfolio
+3.96%
Quarters Held
15
position exited
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 18.8K | $7M | +3.96% |
| Q2 2025 | 18.8K | $8M | +4.93% |
| Q1 2025 | 41.0K | $20M | +9.89% |
| Q4 2024 | 41.0K | $17M | +8.88% |
| Q3 2024 | 41.0K | $19M | +9.55% |
| Q2 2024 | 41.0K | $19M | +9.90% |
| Q1 2024 | 41.0K | $17M | +7.74% |
| Q4 2023 | 48.0K | $20M | +7.52% |
| Q3 2023 | 42.4K | $15M | +5.42% |
| Q2 2023 | 42.4K | $15M | +4.97% |
| Q4 2022 | 16.5K | $5M | +1.93% |
| Q3 2022 | 39.8K | $12M | +3.49% |
| Q2 2022 | 73.1K | $21M | +4.64% |
| Q1 2022 | 82.8K | $22M | +3.54% |
| Q4 2021 | 59.4K | $13M | +1.69% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridger Management, LLC’s full portfolio or all institutional holders of VRTX.